We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

209 hedge funds and large institutions have $1.26B invested in BioTelemetry, Inc. in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 72 increasing their positions, 78 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $10.1M

8% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 78

5% less funds holding

Funds holding: 219209 (-10)

17% less capital invested

Capital invested by funds: $1.53B → $1.26B (-$267M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
209
Holders Change
-10
Holders Change %
-4.57%
% of All Funds
4.61%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
27
Increased
72
Reduced
78
Closed
34
Calls
$12.7M
Puts
$10.1M
Net Calls
+$2.54M
Net Calls Change
+$8.22M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$193M -$8.65M -187,806 -4%
ACH
2
ArrowMark Colorado Holdings
Colorado
$170M +$45M +978,349 +28%
Vanguard Group
3
Vanguard Group
Pennsylvania
$148M +$3.47M +75,399 +2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$48.1M -$2.69M -58,477 -4%
CS
5
Credit Suisse
Switzerland
$41.9M +$69.1K +1,500 +0.1%
State Street
6
State Street
Massachusetts
$40.8M +$3.26M +70,906 +7%
SIMG
7
Stephens Investment Management Group
Texas
$35.6M +$3.3M +71,681 +8%
Loomis, Sayles & Company
8
Loomis, Sayles & Company
Massachusetts
$25.8M +$3.56M +77,376 +13%
RIM
9
Ranger Investment Management
Texas
$23.4M -$825K -17,910 -3%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$22.2M -$114K -2,466 -0.4%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$19.2M +$1.47M +31,893 +7%
RCAMU
12
Rothschild & Co Asset Management US
Connecticut
$18.8M -$2.92M -63,400 -11%
EAM
13
Eagle Asset Management
Florida
$18.8M -$78K -1,695 -0.3%
Northern Trust
14
Northern Trust
Illinois
$18.5M +$144K +3,124 +0.7%
CTA
15
Carillon Tower Advisers
Florida
$16.7M -$520K -11,300 -2%
Norges Bank
16
Norges Bank
Norway
$16.4M
Russell Investments Group
17
Russell Investments Group
United Kingdom
$15.7M -$871K -18,920 -4%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$15.5M -$270K -5,855 -1%
PCM
19
Palisade Capital Management
New Jersey
$14.5M +$704K +15,284 +4%
Truist Financial
20
Truist Financial
North Carolina
$14.2M +$8.1K +176 +0%
Legal & General Group
21
Legal & General Group
United Kingdom
$12.4M +$267K +5,803 +2%
SCA
22
Summit Creek Advisors
Minnesota
$11.3M -$1.68M -36,410 -11%
JP Morgan Chase
23
JP Morgan Chase
New York
$10.5M +$2.43M +52,743 +24%
Principal Financial Group
24
Principal Financial Group
Iowa
$10.2M -$482K -10,479 -4%
RA
25
Royce & Associates
New York
$9.64M -$3.11M -67,500 -21%

BEAT Hedge Fund Activity: Q1 2020 in Review

209 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2020, worth a combined $1.26B — down 17% from $1.53B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of BEAT and 27 opened new positions — a net loss of 7 holders — while 78 trimmed existing stakes and 72 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $45M. The largest seller was Invesco, cutting an estimated $42.1M.

  • 209 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2020, down from 219 in Q4 2019.
  • Funds reported $1.26B of BioTelemetry, Inc. stock for Q1 2020, down 17% quarter-over-quarter.
  • 27 funds opened new BioTelemetry, Inc. positions in Q1 2020 and 34 closed out, a net change of -7 holders.
  • The largest BioTelemetry, Inc. buyer in Q1 2020 was ArrowMark Colorado Holdings, an estimated $45M added.
  • The largest BioTelemetry, Inc. seller in Q1 2020 was Invesco, an estimated $42.1M sold.

Based on aggregated 13F filings for Q1 2020.